About
Inhalon Biopharma Inc develops inhaled monoclonal antibody therapies for the prevention and treatment of acute respiratory infections including RSV, influenza, SARS-CoV-2, and metapneumovirus.
Explore Inhalon Biopharma Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.